Vascular Endothelial Growth Factors

• VEGF Inhibitors Update & Drug Evaluation - Apr 04, 2024
• Ocular VEGF inhibitors - Aug 06, 2020
• VEGF Inhibitors Class Update - May 25, 2017
• VEGF Inhibitors Class Update - Jan 29, 2015
• Abbreviated Review: Vascular Endothelial Growth Factor (VEGF) Inhibitors - Nov 29, 2012

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.